Back
ESC2025 Premium Access

Echocardiographic risk stratification in light chain and transthyretin amyloidosis: a meta-analysis

Session: Imaging in left ventricular hypertrophy phenotype
Topic: Myocardial Disease
Speaker: Doctor D. Koeckerling (Heidelberg, DE)
Event: ESC Congress 2025

Congress Presentation

Add to my library

Like

About the speaker

Doctor David Koeckerling

University Hospital Heidelberg, Heidelberg (Germany)
0 follower

7 more presentations in this session

Fatty liver disease as risk factors for the clinical expression of hypertrophic cardiomyopathy

Speaker: Doctor Y. Ahn (Seoul, KR)

Access
Abstract
Slides
Video
Like
Thumbnail

Clinical and mechanical characterestics of familial hypertrophic cardiomyopathy. Prediction and prognostic implication

Speaker: Professor H. Badran (Shibin El Kom, EG)

Access
Abstract
Slides
Video
Like
Thumbnail

Mechanical features and survival of children with hypertrophic cardiomyopathy

Speaker: Professor H. Badran (Shibin El Kom, EG)

Access
Abstract
Slides
Video
Like
Thumbnail

Evolution of cardiac damage staged with echocardiography in Fabry disease

Speaker: Doctor R. Lillo (Rome, IT)

Access
Abstract
Slides
Video
Like
Thumbnail

Biomarkers of atrial remodelling and risk of cardiovascular death in patients with hypertension: the LOOP study

Speaker: Doctor A. Langhoff (Copenhagen, DK)

Access
Abstract
Slides
Video
Like
Thumbnail

Access the full session

Imaging in left ventricular hypertrophy phenotype

Speakers: Doctor D. Koeckerling, Doctor Y. Ahn, Professor H. Badran, Professor H. Badran, Doctor R. Lillo...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources